hrp0094p1-186 | Pituitary B | ESPE2021

Additive effect of androgens and estrogens on pubertal growth acceleration

Huttunen Heta , Varimo Tero , Huopio Hanna , Voutilainen Raimo , Tenhola Sirpa , Miettinen Paivi , Raivio Taneli , Hero Matti ,

Objective: The influence of androgens and estrogens on growth is complex, and understanding their relative roles is important for optimizing the treatment of children with various disorders of growth and puberty.Design: We examined the proportional roles of androgens and estrogens in the regulation of pubertal growth in boys with constitutional delay of growth and puberty (CDGP). The study compared 6-month low-dose intramuscular testoste...

hrp0097p1-88 | Fetal, Neonatal Endocrinology and Metabolism | ESPE2023

The variable outcome of childhood growth in congenital hyperinsulinism

Väätänen Oona , Saari Antti , Huopio Hanna , M.E. Männistö Jonna

Background: There is limited knowledge about the natural history of growth in patients with congenital hyperinsulinism (CHI). The disease itself, as well as its treatment methods with common long-term sequalae in terms of pancreatic endocrine and exocrine dysfunction have the potential to affect growth. We investigated longitudinal height growth of CHI patients in a large Finnish cohort.Materials and methods: In this cro...

hrp0095fc1.2 | Thyroid | ESPE2022

Comorbidity in congenital hypothyroidism - A nationwide population-based cohort study

Danner Emmi , Jääskeläinen Jarmo , Huopio Hanna , Niuro Laura , Niinikoski Harri , Kero Jukka , Sund Reijo

Aim of the study: The aim of this nationwide population-based register study was to investigate the incidence of congenital malformations, neonatal and chronic comorbidities, and the use of prescribed drugs in patients with primary congenital hypothyroidism (CH).Methods: The study cohort and matched controls were identified from national population-based registers in Finland (The Social Insurance Institution of Finland a...

hrp0092rfc15.4 | Late Breaking Abstracts | ESPE2019

Clinical and Genetic Characterization of 148 Patients with Persistent or Transient Congenital Hyperinsulinism: A Population-Based Study in Finns

Männistö Jonna , Maria Maleeha , Raivo Joose , Kuulasmaa Teemu , Otonkoski Timo , Huopio Hanna , Laakso Markku

Context: Major advances have been made in the genetics and classification of congenital hyperinsulinism (CHI; OMIM #256450).Objective: To examine the molecular and clinical characteristics of the Finnish patients with persistent and transient CHI.Design: A cross-sectional study with the register data and targeted sequencing of 104 genes affecting glucose metabolism.<p class="ab...

hrp0098fc1.6 | Diabetes and Insulin | ESPE2024

Comprehensive rescreening of the known congenital hyperinsulinism genes provides a new genetic diagnosis for 18% of the Finnish cohort

M E Männistö Jonna , A L Houghton Jayne , Keskinen Päivi , Hopkins Jasmin , Raivo Joose , Otonkoski Timo , Huopio Hanna , E Flanagan Sarah

Background: Congenital hyperinsulinism (HI) is a group of insulin secretion disorders with highly heterogeneous genetic aetiologies, which may significantly impact on treatment and follow-up. Genetic diagnosis is unsolved in up to 50% of the individuals, but the benefits of retesting including all the recent genetic discoveries has not been previously assessed.Aim: We examined the effectiveness of rescreening the known H...